Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Avotermin

Generic Name: Avotermin

Drug Type: Biotech

CAS Number: 182212-66-4

Unique Ingredient Identifier: 2Q1GS25JWN

Overview

Juvista has been investigated for the treatment, prevention, and basic science of Scars, Keloid, and Cicatrix.

Background

Juvista has been investigated for the treatment, prevention, and basic science of Scars, Keloid, and Cicatrix.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Trial to Compare the Efficacy of Two Formulations of Avotermin Against Placebo

Phase 1

Completed

Posted: 2009/12/09

Sponsor:

Renovo

ID:NCT01029158

Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites

Phase 2

Completed

Posted: 2009/09/25

Sponsor:

Renovo

ID:NCT00984503

Safety and Efficacy Study of Avotermin (Juvista) in Female Subjects

Phase 1

Completed

Posted: 2009/09/25

Sponsor:

Renovo

ID:NCT00984581

Investigation of the Safety, Dosing Frequency and Anti-Scarring Potential of Two Concentrations of Intradermal Avotermin (Juvista)

Phase 1

Completed

Posted: 2009/09/16

Sponsor:

Renovo

ID:NCT00978367

Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista)

Phase 1

Completed

Posted: 2009/09/16

Sponsor:

Renovo

ID:NCT00978302

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy